PATENT CLAIM ANALYSIS

Application Number: 15933619
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "140100"]

Abstract:
Disclosed is a method for treating of Cockayne Syndrome (CS). Specifically, the invention pertains to a method for the extracorporeal treatment of a body fluid by removing the body fluid from a living body diseased with CS, and applying a targeted antibody conjugated to a moiety to at least one Cockayne Syndrome antigen in the body fluid, creating an antibody-antigen moiety complex, removing antibody-antigen moiety complex from the body fluid, and returning the purified body fluid to the body.

Claim (Index 1):
A method for the extracorporeal treatment of a body fluid carrying at least one Cockayne Syndrome Targeted Antigen (CSTA) comprising:\n treating the body fluid carrying at least one unbound CSTA with at least one CSTA targeted antibody in an amount sufficient to bind all the at least one unbound CSTA forming CSTA target antibody-CSTA complexes, wherein the at least one CSTA targeted antibody is conjugated with a moiety; removing the CSTA targeted antibody-CSTA complexes from the body fluid; and identifying any remaining CSTA targeted antibody-CSTA complexes.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.91304
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15647850', '14978910', '09562245', '13254855', '10461885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6473772324150541
- 35 USC 102 Novelty (BERT): 0.4574701256840796
- Combined Prediction Score: 0.6283865217419566
- Mean Citation Score: 130.47465
- Max Citation Score: 132.54641999999998
- Similarity Product: 107.07715180384396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test